Turn Therapeutics (TTRX) Operating Income (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Operating Income of -$1.2 million for Q1 2026, down 223.68% year-over-year from $1.0 million in Q1 2025, and up 43.19% quarter-over-quarter from -$2.2 million in Q4 2025.
Turn Therapeutics (TTRX) Operating Income (2024 - 2026) Analysis & Trends
Turn Therapeutics' Operating Income history runs 3 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- In Q1 2026, Operating Income fell 223.68% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$5.7 million (changed N/A YoY), while the FY2025 annual figure was -$5.9 million, down 226.0% from the prior year.
- Operating Income for Q1 2026 stood at -$1.2 million, up from -$2.2 million in the prior quarter.
- The five-year high for Operating Income was -$328957.0 in Q4 2024, with the low at -$2.2 million in Q4 2025.
- The 3-year median for Operating Income is -$959567.5 (2024), against an average of -$1.1 million.
- Peak annual rise in Operating Income reached 184.34% in 2025, while the deepest fall reached 566.83% in 2025.
- Turn Therapeutics' Operating Income stood at -$328957.0 in 2024, then plunged by 566.83% to -$2.2 million in 2025, then surged by 43.19% to -$1.2 million in 2026.
- Business Quant data shows TTRX's Operating Income at -$1.2 million in Q1 2026, -$2.2 million in Q4 2025, and -$1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Turn Therapeutics | 285.07 Mn | 285.07 Mn | - | -1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.63 Mn |
| Mar 31, 2026 | -1.25 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Mar 31, 2025 | -384,997.00 |
| Dec 31, 2024 | -328,957.00 |
| Sep 30, 2024 | -672,992.00 |